Answers are grounded in this paper and cite their sources.
The use of comparative liquid chromatography/mass spectrometry-based lipidomics and metabolomics allows the discovery of novel pathways in atherogenesis, as well as new potential plasma biomarkers, which could allow us to predict disease in its early stages and measure its progression.
No takes yet. Share an insight, caveat, or question.
Jové et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: